(Q36665436)

15 August 2017

1 reference

title

Diabetes and heart failure in the post-myocardial infarction patient (English)

1 reference

15 August 2017

1 reference

Jerry D Estep

1

1 reference

15 August 2017

David Aguilar

series ordinal

2

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Current heart failure reports

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

164-169

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-006-0017-7

15 August 2017

exact match

0 references

cites work

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11897-006-0017-7

Chronic heart failure in the United States: a manifestation of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-006-0017-7

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-006-0017-7

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-006-0017-7

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

21 January 2018

1 reference

12 December 2020

Insulin resistance and risk of congestive heart failure

1 reference

12 December 2020

Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials

1 reference

12 December 2020

Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction

1 reference

12 December 2020

Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction

1 reference

12 December 2020

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.

1 reference

12 December 2020

Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.

1 reference

12 December 2020

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

1 reference

12 December 2020

Predictors of late development of heart failure in stable survivors of myocardial infarction

1 reference

12 December 2020

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

12 December 2020

Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention tria

1 reference

12 December 2020

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

1 reference

12 December 2020

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction

1 reference

12 December 2020

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

12 December 2020

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

12 December 2020

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

1 reference

12 December 2020

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

12 December 2020

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

12 December 2020

Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction

1 reference

12 December 2020

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

12 December 2020

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

1 reference

12 December 2020

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

1 reference

12 December 2020

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

1 reference

12 December 2020

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

1 reference

12 December 2020

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

12 December 2020

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

1 reference

12 December 2020

Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction

1 reference

12 December 2020

The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart.

1 reference

12 December 2020

Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group

1 reference

12 December 2020

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

1 reference

12 December 2020

Lifetime Risk for Diabetes Mellitus in the United States

1 reference

12 December 2020

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

1 reference

12 December 2020

Therapies to prevent heart failure post-myocardial infarction

1 reference

12 December 2020

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

12 December 2020

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).

1 reference

12 December 2020

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

12 December 2020

Blunted sympathetic response in diabetic patients with decompensated congestive heart failure

1 reference

12 December 2020

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

12 December 2020

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

12 December 2020

Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction

1 reference

12 December 2020

10.1007/S11897-006-0017-7

Identifiers

DOI

1 reference

15 August 2017

1 reference